CHI Pharma Partners Getz To Boost Drug Access, Improve Healthcare Delivery

To expand the availability of essential medicines across Nigeria, Getz Pharma Nigeria Limited has partnered with CHI Pharmaceuticals Limited, a member of Tropical General Investments (TGI) Group, to leverage its nationwide distribution network. This partnership marks a significant step toward improving access to quality healthcare nationwide.

This was announced during a strategy session at CHI Pharma’s Lagos headquarters. The partnership gives Getz Pharma access to over 5,000 registered pharmaceutical outlets already covered by CHI Pharma, a network that reaches more than half of Nigeria’s licensed pharmacies.

“This is not just another handshake,” said Shriram Iyer, Chief Operating Officer at CHI Pharma. “Getz Pharma chose us for a reason. We have built deep relationships across Nigeria’s pharmaceutical landscape for almost three decades. They are tapping into that infrastructure to bring life saving medications closer to the people who need them most.”

The collaboration, formalised after six months of due diligence, is built on a multiple distribution model that ensures product availability and business continuity.

“Patients suffer when quality drugs are unavailable,” said Syed Khairat Haider, General Manager – Commercial, Getz Pharma Nigeria. “This model ensures pharmacies and hospitals always have access. We are investing in sustainability, scale, and speed.”

With a combined field force of over 60 people focused on activation, awareness, and distribution, the partnership allows each company to focus on their core strengths: Getz Pharma will drive physician engagement and education, while CHI Pharma manages last-mile delivery and retail placement.

“We have built this model to ensure deep penetration of Getz Pharma brands into pharma channels such as wholesale pharmacies, retail pharmacies”, added Timothy Olabiyi, Sales Director for General Trade at CHI Pharma. “We have done this successfully with over 17 other partners, and each time, the focus is the same: access, affordability, and ethical distribution.”

While CHI Pharma’s proprietary brands like Supramult® and Co-Mal® continue under a separate umbrella, the Getz partnership, like other distribution partnerships, will be carried out by our field force, solely focused on product placement and visibility within pharma channels.

“Within the first few days of activation/ launch, we have already surpassed our initial sales targets,” said Haider. “This is just the beginning. We are looking to expand into biologics and innovative therapies to raise the standard of care in Nigeria.

This new alliance follows recent CHI Pharma collaborations with EVA Pharma and Neimeth International Pharmaceuticals, reinforcing the company’s role as a trusted distribution partner for global and local pharmaceutical players targeting Nigeria.